TimePLENARY SESSION TimeBREAKOUT SESSION TimeNON-CME Track (Symposia) 
TopicSpeakerTopicSpeakerTopicSpeakerFormat
13:00 - 13: 30Check-in
13:30 - 14:00NetworkingNetworkingNetworking
Session 1: Lymphoproliferative & Plasma Cell Myeloma Disorders14:00 - 15:00Workshop 1: Study Design
14:00 - 14:20Update on the management of CLLPaolo Ghia14:00 - 14:30Symposium 1Simu-Live
14:20 - 14:40PET adapted therapy in Hodgkin LymphomaAndrea Gallamini
14:40 - 15:00Update on the management of FLAndrew Davis14:30 - 1500Symposium 2Simu-Live
15:00 - 15:20PCM: DO we still need upfront ASCT?Evangelos Terpos
15:20 - 15:30QnA
15:30 - 15:45Networking BreakNetworking BreakNetworking Break
Session 2: Keynote Session15:50 - 16:50Workshop 2: Pediatric Palliative Care I
15:45 - 15:50Opening RemarksAbdulhakim AlRawas
15:50 - 16:05Honorary LectureTBA15:45 - 16:15Symposium 3Simu-Live
16:05 - 16:35State of Art Lecture: CAR T-Cell Therapy in Hematologic MalignanciesStephen Gottschalk
16:35 - 16:40QnA16:15 - 16:45Symposium 4Simu-Live
16:40 - 16:50Closing Remarks
16:50 - 17:20NetworkingNetworking
TimePLENARY SESSION TimeNON-CME Track (Symposia)
TopicSpeakerTopicSpeaker
13:00 - 13:30Check-in
13:30 - 14:00NetworkingNetworking
14:00 - 14:05Opening RemarksAbdulhakim AlRawas
Session 3: Bone Marrow Failure
14:05 - 14:25Neutropenia in paediatric age groupChristoph Klein 14:05 - 14:35Symposium 5
Updates on diagnosis and management of fanconi anaemiaMathew Zachariah
14:45 - 15:05 Immune Diseases for HematologistsChristoph Klein 14:35 - 15:05Symposium 6
15:05 15:10QnA
Session 4: Myeloproliferative Disorders
15:10 - 15:30Management of Chronic Myeloid Leukemia in Children and AdolescentsAnupama Rao
15:30 - 15:50JAK- inhibitors where they fit in Management of MPDShireen Sarhan
15:50 - 16:10Management of MPN in the COVID-19 Pandemic EraShireen Sarhan
16:10 - 16:!5QnA
16:15 - 16:35Networking BreakNetworking Break
16:35 - 17:35Workshop 2: Pediatric Palliative Care II16:35 - 17:05Symposium 7
17:35 - 1745Closing Remarks17:05 - 1735Symposium 8
17:45 - 18:15Networking
TimePLENARY SESSIONTimeNON-CME Track (Symposia)
TopicSpeakerTopicSpeaker
13:00 - 13:30Check-in
13:30 - 14:00NetworkingNetworking
14:00 - 14:05Opening RemarksAbdulhakim AlRawas
Session 5: Bone Marrow Transplantation
14:05 - 14:25Use of PTCY as GVHD Prophylaxis Mohamed Mohty14:05 - 14:35Symposium 9
14:25 - 14:45"Limited Transplant Indication" PartMiguel Abboud
14:45 - 15:05"Transplant for All" PartSelim Corbacioglu14:35 - 15:05Symposium 10
15:05 - 15:25Haploidentical transplant in bone marrow failureMohab Ayas
15:25 - 15:30QnA
15:30 - 15:45Networking BreakNetworking Break
Session 6: Thrombosis & Hemostasis
14:45 - 16:05Use of DOAC in pediatric venous thromboembolism (VTE)Anthony Chan15:45 - 16:!5Symposium 11
16:05 - 16:25Immune tolerance induction (ITI) VS emicizumab in patients with hemophilia A and high Titre inhibitorAnthony Chan
16:25 - 15:45Immune tolerance induction (ITI) VS emicizumab in patients with hemophilia A and high Titre inhibitorGerard Dolan16:15 - 16:45Symposium 12
16:45 - 17:05Catastrophic antiphospholipid syndrome - management and updateTBA
17:05 - 17:10QnA
17:10 - 17:25Networking BreakNetworking Break
Session 7: Acute Leukemia
17:25 - 17:45Management of AML in patients fit for intensive chemotherapy: UpdatesTBA
17:45 - 18:05Role of MRD in AML and incorporation of the results in the managementChristian Thiede
18:05 - 18:25Management of relapsed refractory ALL: Updates TBA
18:25 - 18:35QnA
18:35 - 18:45Closing Remarks
18:45 - 19:1NetworkingNetworking
TimePLENARY SESSION 
TopicSpeaker
13:00 - 13:30Check-in
13:30 - 14:00Networking
14:00 - 14:05Opening Remarks
Session 8: Transfusion Medicine
14:05 - 14:25Impact of COVID-19 on blood donations in Dubai Blood CenterMay Raouf
14:25 - 14:45Mass Casualty Events: Transfusion blood bank and transfusion service perspectivePierre Tiberghien
14:45 - 15:05Protecting blood supply during emergency situation, challenges and proposed actionsYuyun Maryuningsih
15:05 - 15:25Protecting the blood supply during infectious disease outbreakAbdellah Yetmgeta
15:25 - 15:30QnA
15:30 - 15:45Networking Break
Session 9: Hematological Complications in Pregnancy
15:45 - 16:05ITP in pregnancy the Omani experienceSulayma Al Lamki
16:05 - 16:25Major challenges of B Thalassaemia in pregnancyFarrukh Shah
16:25 - 16:45TTP in peipartum periodChristie Kim
16:45 - 17:05Thrombosis in pregnancyChristie Kim
17:05 - 17:!5QnA
17:15 - 17:25Closing Remarks
17:25Networking
TimePLENARY SESSION 
TopicSpeaker
13:00 - 13:30Check-in
13:30 - 14:00Networking
14:00 - 14:05Opening RemarksAbdulhakim AlRawas
Session 10: Haemoglobinopathies & Red Cell Disorders
14:05 - 14:25Debate: Hydroxyurea use in SCD in Gulf Area: Is it for all patients?Wasil Jastaniah
14:25 - 14:45Debate: Hydroxyurea use in SCD in Gulf Area: Is it for all patients?Yasser Wali
14:45 - 15:05Peri-surgical management and complications in sickle cell diseaseWasil Jastaniah
15:05 - 15:25Cases studies in Rare AnaemiasTBA
15:25 - 15:35QnA
15:35 - 15:55Networking Break
Session 11: Abstract Session
15:55 - 16:05Abstract 1TBC
16:05 - 16:15Abstract 2TBC
16:15 - 16:25Abstract 3TBC
16:25 - 16:35Abstract 4TBC
16:35 - 16:45Abstract 5TBC
16:45 - 15:55Abstract 6TBC
16:55 - 17:05Abstract 7TBC
17:05 - 17:!5Abstract 8TBC
17:15 - 17:25Closing RemarksAbdulhakim AlRawas
17:25 - 17:55Networking
Day 1- 15 OCT 2020
TimePLENARY SESSION TimeBREAKOUT SESSION TimeNON-CME Track (Symposia) 
TopicSpeakerTopicSpeakerTopicSpeakerFormat
13:00 - 13: 30Check-in
13:30 - 14:00NetworkingNetworkingNetworking
Session 1: Lymphoproliferative & Plasma Cell Myeloma Disorders14:00 - 15:00Workshop 1: Study Design
14:00 - 14:20Update on the management of CLLPaolo Ghia14:00 - 14:30Symposium 1Simu-Live
14:20 - 14:40PET adapted therapy in Hodgkin LymphomaAndrea Gallamini
14:40 - 15:00Update on the management of FLAndrew Davis14:30 - 1500Symposium 2Simu-Live
15:00 - 15:20PCM: DO we still need upfront ASCT?Evangelos Terpos
15:20 - 15:30QnA
15:30 - 15:45Networking BreakNetworking BreakNetworking Break
Session 2: Keynote Session15:50 - 16:50Workshop 2: Pediatric Palliative Care I
15:45 - 15:50Opening RemarksAbdulhakim AlRawas
15:50 - 16:05Honorary LectureTBA15:45 - 16:15Symposium 3Simu-Live
16:05 - 16:35State of Art Lecture: CAR T-Cell Therapy in Hematologic MalignanciesStephen Gottschalk
16:35 - 16:40QnA16:15 - 16:45Symposium 4Simu-Live
16:40 - 16:50Closing Remarks
16:50 - 17:20NetworkingNetworking
Day 2 - 16 OCT 2020
TimePLENARY SESSION TimeNON-CME Track (Symposia)
TopicSpeakerTopicSpeaker
13:00 - 13:30Check-in
13:30 - 14:00NetworkingNetworking
14:00 - 14:05Opening RemarksAbdulhakim AlRawas
Session 3: Bone Marrow Failure
14:05 - 14:25Neutropenia in paediatric age groupChristoph Klein 14:05 - 14:35Symposium 5
Updates on diagnosis and management of fanconi anaemiaMathew Zachariah
14:45 - 15:05 Immune Diseases for HematologistsChristoph Klein 14:35 - 15:05Symposium 6
15:05 15:10QnA
Session 4: Myeloproliferative Disorders
15:10 - 15:30Management of Chronic Myeloid Leukemia in Children and AdolescentsAnupama Rao
15:30 - 15:50JAK- inhibitors where they fit in Management of MPDShireen Sarhan
15:50 - 16:10Management of MPN in the COVID-19 Pandemic EraShireen Sarhan
16:10 - 16:!5QnA
16:15 - 16:35Networking BreakNetworking Break
16:35 - 17:35Workshop 2: Pediatric Palliative Care II16:35 - 17:05Symposium 7
17:35 - 1745Closing Remarks17:05 - 1735Symposium 8
17:45 - 18:15Networking
Day 3 - 17 OCT 2020
TimePLENARY SESSIONTimeNON-CME Track (Symposia)
TopicSpeakerTopicSpeaker
13:00 - 13:30Check-in
13:30 - 14:00NetworkingNetworking
14:00 - 14:05Opening RemarksAbdulhakim AlRawas
Session 5: Bone Marrow Transplantation
14:05 - 14:25Use of PTCY as GVHD Prophylaxis Mohamed Mohty14:05 - 14:35Symposium 9
14:25 - 14:45"Limited Transplant Indication" PartMiguel Abboud
14:45 - 15:05"Transplant for All" PartSelim Corbacioglu14:35 - 15:05Symposium 10
15:05 - 15:25Haploidentical transplant in bone marrow failureMohab Ayas
15:25 - 15:30QnA
15:30 - 15:45Networking BreakNetworking Break
Session 6: Thrombosis & Hemostasis
14:45 - 16:05Use of DOAC in pediatric venous thromboembolism (VTE)Anthony Chan15:45 - 16:!5Symposium 11
16:05 - 16:25Immune tolerance induction (ITI) VS emicizumab in patients with hemophilia A and high Titre inhibitorAnthony Chan
16:25 - 15:45Immune tolerance induction (ITI) VS emicizumab in patients with hemophilia A and high Titre inhibitorGerard Dolan16:15 - 16:45Symposium 12
16:45 - 17:05Catastrophic antiphospholipid syndrome - management and updateTBA
17:05 - 17:10QnA
17:10 - 17:25Networking BreakNetworking Break
Session 7: Acute Leukemia
17:25 - 17:45Management of AML in patients fit for intensive chemotherapy: UpdatesTBA
17:45 - 18:05Role of MRD in AML and incorporation of the results in the managementChristian Thiede
18:05 - 18:25Management of relapsed refractory ALL: Updates TBA
18:25 - 18:35QnA
18:35 - 18:45Closing Remarks
18:45 - 19:1NetworkingNetworking
Day 4 - 18 OCT 2020
TimePLENARY SESSION 
TopicSpeaker
13:00 - 13:30Check-in
13:30 - 14:00Networking
14:00 - 14:05Opening Remarks
Session 8: Transfusion Medicine
14:05 - 14:25Impact of COVID-19 on blood donations in Dubai Blood CenterMay Raouf
14:25 - 14:45Mass Casualty Events: Transfusion blood bank and transfusion service perspectivePierre Tiberghien
14:45 - 15:05Protecting blood supply during emergency situation, challenges and proposed actionsYuyun Maryuningsih
15:05 - 15:25Protecting the blood supply during infectious disease outbreakAbdellah Yetmgeta
15:25 - 15:30QnA
15:30 - 15:45Networking Break
Session 9: Hematological Complications in Pregnancy
15:45 - 16:05ITP in pregnancy the Omani experienceSulayma Al Lamki
16:05 - 16:25Major challenges of B Thalassaemia in pregnancyFarrukh Shah
16:25 - 16:45TTP in peipartum periodChristie Kim
16:45 - 17:05Thrombosis in pregnancyChristie Kim
17:05 - 17:!5QnA
17:15 - 17:25Closing Remarks
17:25Networking
Day 5 - 19 OCT 2020
TimePLENARY SESSION 
TopicSpeaker
13:00 - 13:30Check-in
13:30 - 14:00Networking
14:00 - 14:05Opening RemarksAbdulhakim AlRawas
Session 10: Haemoglobinopathies & Red Cell Disorders
14:05 - 14:25Debate: Hydroxyurea use in SCD in Gulf Area: Is it for all patients?Wasil Jastaniah
14:25 - 14:45Debate: Hydroxyurea use in SCD in Gulf Area: Is it for all patients?Yasser Wali
14:45 - 15:05Peri-surgical management and complications in sickle cell diseaseWasil Jastaniah
15:05 - 15:25Cases studies in Rare AnaemiasTBA
15:25 - 15:35QnA
15:35 - 15:55Networking Break
Session 11: Abstract Session
15:55 - 16:05Abstract 1TBC
16:05 - 16:15Abstract 2TBC
16:15 - 16:25Abstract 3TBC
16:25 - 16:35Abstract 4TBC
16:35 - 16:45Abstract 5TBC
16:45 - 15:55Abstract 6TBC
16:55 - 17:05Abstract 7TBC
17:05 - 17:!5Abstract 8TBC
17:15 - 17:25Closing RemarksAbdulhakim AlRawas
17:25 - 17:55Networking